Clinical Trial Update: Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for AstroStem-V in COVID-19 pneumonia across Phase 1 and Phase 2, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• AstroStem-V

Snippet

Sponsor: Nature Cell Co. Ltd. | Conditions: Covid19 Pneumonia | Phase 1, Phase 2 | Status: UNKNOWN